Lin PC, Yeh YM, Chan RH, Lin BW, et al. Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy. BMC Cancer 2021;21:217.
PMID: 33653301